K100090 · Genicon · FZP · Feb 2, 2010 · General, Plastic Surgery
Device Facts
Record ID
K100090
Device Name
IMPLANTABLE CLIP
Applicant
Genicon
Product Code
FZP · General, Plastic Surgery
Decision Date
Feb 2, 2010
Decision
SESE
Submission Type
Special
Regulation
21 CFR 878.4300
Device Class
Class 2
Attributes
Therapeutic
Intended Use
The GENICON implantable clips are intended for use during procedures for the purpose of approximating soft tissue, closing off vessels and other structures in order to stop bleeding or to connect internal tissues to aid in healing.
Device Story
Titanium ligation clips used for hemostasis and tissue approximation during surgical procedures. Clips are supplied in various sizes (mini-micro to extra large) on disposable holders. Device is applied by surgeons to close vessels or connect internal tissues to facilitate healing. Titanium material provides biocompatibility for long-term implantation. Device functions as a mechanical fastener; no electronic or software components.
Clinical Evidence
No clinical data. Substantial equivalence is based on established material safety (titanium) and historical clinical acceptance of titanium ligation clips since the 1960s.
Technological Characteristics
Material: Grade I Titanium per ASTM F-67 95 and ISO 5832-2-93. Form factor: Sterile, disposable clips in various sizes (mini-micro to extra large) on disposable holders. Mechanical ligation principle. Manufactured per GMP, AAMI, and ISO 13485 standards.
Indications for Use
Indicated for use in surgical procedures requiring approximation of soft tissue or ligation of vessels and structures to achieve hemostasis or tissue connection.
Regulatory Classification
Identification
An implantable clip is a clip-like device intended to connect internal tissues to aid healing. It is not absorbable.
{0}------------------------------------------------
K100090
FEB - 2 2010
## 510(k) Summary Statement
Submitters Name: GENICON 6869 Sta Point Court Suite #114 Winter Park, FL 32792 Ph: 1.321.297.1189 Fx: 1.407.679.0880
Contact Name: Melanie Murphy
Name of Device: Titanium Ligation Clip
Safety & Effectiveness Data Summary:
Classification Name: Clip, Implantable Common/Usual Name: Ligation Clip Proprietary Name: n/a at this time
Classification: Class II
| Implantable Clip: | #79 FZP | |
|-------------------|---------|------------------------------------------------------------------------------------------------------------------------|
| Hemostatic Clip: | | #79 MCH Reg. #878.4300 - 36-2 - 1. 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 " " " " " " " " " " " " " " " " " " " " " " " " " " |
Performance Standards: Devices are manufactured according to Good Manufacturing Practices (G.M.P.), Association for Advancement of Medical Instrumentation (A.A.M.I.) and American Society for Testing and Materials (A.S.T.M.) requirements and applicable Harmonized Standards ISO 13485.
Material Composition: A.S.T.M F-67 95, Grade I Titanium I.S.O. #5832-2-93, Grade I Titanium
Intended Use: The GENICON implantable clips are intended for use during procedures for the purpose of approximating soft tissue, closing off vessels and other structures in order to stop bleeding or to connect internal tissues to aid in healing.
Device Description: The ligation clips are composed exclusively of titanium, and are supplied as sterile products in various sizes (mini-micro, micro, smallmedium, medium, medium-large, large and extra large) with six clips per disposable holder. The titiaum used meets all requirements for A.S.T.M. specifications F-67 95 "Unalloyed Titanium for Surgical Implant Applications", Grade I and ISO 5832-2-93 and 10993 "Implants for Surgery - Metallic Materials - Part 2: Unalloyed Titanium".
Predicate Devices: Ethicon K830503
{1}------------------------------------------------
Comparison of Technological Characteristics: The titanium clip material and disposable holder material substantially equivalent to the predicate device. In function, the clips are the substantially equivalent to the predicate device as well.
ﻣﺎ ﺟ
(
Safety and Efficacy Information: Titanium is well recognized as being safe and effective for long term implantation. Millions of titanium clips are applied yearly and since inception in the 1960's attest to the wide acceptance of this method of hemostatic and ligation control.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a circular arrangement of text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA". Inside the circle is an abstract emblem resembling an eagle or a stylized human figure, composed of three curved lines. The emblem is positioned to the right of the text.
## Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-066-0609 Silver Spring, MD 20993-0002
FEB - 2 2010
Genicon % Mr. Gary W. Haberland President 6869 Stapoint Court #114 Winter Park, Florida 32792
Re: K100090
Trade/Device Name: Genicon Ligation Clip Regulation Number: 21 CFR 878,4300 Regulation Name: Implantable clip Regulatory Class: Class II Product Code: FZP, MCH Dated: January 08, 2010 Received: January 12, 2010
Dear Mr. Haberland:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
{3}------------------------------------------------
Page 2 - Mr. Gary W. Haberland
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.lyfm
Sincerely yours,
Mark N. Melkerson Director Division of Surgical, Orthopedic And Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
12,100090 510(k):
Section 4 - Indications for Use
·Device Name: GENICON Ligation Clip
Indications for Use:
The GENICON implantable clips are intended for use during procedures for the purpose of approximating soft tissue, closing off vessels and other structures in order to stop bleeding or to connect internal tissues to aid in healing. -
Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
Page 1 of
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
00090
Daniel Keene for MXM
(Division Sign-Off)
Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.